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Figure 2. Pilot data of one subject’s average walking economy for the 
last two minutes during each walking condition.
• The average walking economy for the last two minutes increased 
from 13.559 mL/kg/min to 14.656 mL/kg/min between the NORM 
and SA conditions (8.09% increase)
DISCUSSION
• Results of this study hope to determine normative effects of the 
lower-leg exoskeleton on lower-limb joint angles, torques, and the 
metabolic cost of walking
• If the exoskeleton is able to decrease the metabolic cost of walking, 
or the required biological torque contribution across subjects, the 
device may be beneficial to pathological population who exhibit 
ankle weakness or reduced forward propulsion
REFERENCES
• The ankle produces 60% of the lower-body positive mechanical work 
during the stance phase of gait1,2
• If ankle muscles are weak, there are reductions in the ability to generate 
appropriate torques and powers during walking
• This leads to slower preferred walking speeds (PWS), which correlate 
with poor physical function, more disabilities, increased hospitalization 
visits and costs, and even mortality3,4
• Due to this, many orthotic and exoskeletal devices are being created to 
restore proper ankle function by promoting ankle plantar flexion5,6
• Purpose: Build a passive dynamic lower-leg exoskeleton to assist 
ankle plantar flexion, and assess its effects during walking
• Hypothesis 1: Wearing the exoskeleton will reduce the biological ankle 
torque contribution during stance
• Hypothesis 2: Wearing the exoskeleton will insignificantly affect ankle 
angle throughout gait
• Hypothesis 3: Wearing the exoskeleton will decrease the metabolic 
cost of walking
MATERIALS / METHODS
• Ten young, healthy participants between the ages of 19 and 35 years 
will walk on a level treadmill, at 10% faster than their PWS, for a variety 
of exoskeleton conditions (Table 1)
Table 1. Exoskeleton conditions during level treadmill walking.
• All walking trials will be five minutes long and followed by a three minute 
rest
• Subjects will begin the study with a habituation period on the treadmill, 
involving three walking trials wearing the device with constant 
assistance actuators (CA Condition)
• 3D motion capture (Vicon Nexus) will measure hip, knee, and ankle 
motion in the sagittal plane
• An instrumented treadmill (Bertec) will measure ground reaction forces
• Using inverse dynamics, lower-body joint torques and powers will be 
calculated from motion and force data during walking trials
INTRODUCTION
Exoskeleton Walking Conditions
Normal (No Device) – [NORM]
Exoskeleton without Elastic Actuators – [NA]
Exoskeleton with Constant Actuation – [CA]
Exoskeleton with Stance-Only Actuation – [SA]
EXOSKELETON
• The lower-leg exoskeleton consists of four major components    
(Figure 1):
1. Calf Cuff
2. Passive Clutch
3. Extension Spring (Elastic Actuator)
4. Foot Bracket
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Figure 1. A) Schematic of the passive dynamic lower-leg exoskeleton 
with annotated components, and B) the exoskeleton being worn on the 
treadmill.
• The exoskeleton assists plantar flexion at the end of the stance phase 
of gait, facilitating forward propulsion
• As the ankle angle changes throughout the gait cycle, there is a 
resulting change in the length between the clutch and the heel of the 
foot bracket
• During the stance phase, this stretches the spring as the heel is in 
contact with the ground
• As toe-off begins, the clutch releases the spring, applying a plantar 
flexion torque about the ankle and assisting forward propulsion
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